HC Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,694
| Closed | -$319K | – | 87 |
|
2022
Q1 | $319K | Sell |
2,694
-1,691
| -39% | -$200K | 0.2% | 59 |
|
2021
Q4 | $604K | Buy |
4,385
+694
| +19% | +$95.6K | 0.37% | 41 |
|
2021
Q3 | $513K | Sell |
3,691
-582
| -14% | -$80.9K | 0.34% | 42 |
|
2021
Q2 | $415K | Sell |
4,273
-230
| -5% | -$22.3K | 0.26% | 50 |
|
2021
Q1 | $308K | Buy |
4,503
+782
| +21% | +$53.5K | 0.2% | 57 |
|
2020
Q4 | $319K | Buy |
3,721
+320
| +9% | +$27.4K | 0.22% | 60 |
|
2020
Q3 | $221K | Buy |
+3,401
| New | +$221K | 0.18% | 65 |
|